In November 2021, an exciting new resource will be launched: the Global Drug Policy Index (GDPI). The Index will score and rank countries on how their national drug policies align with the international best practice in terms of health, criminal justice, access to medicines, and development.
In the first year, the GDPI shall focus on 30 selected countries from all around the world. For each country, data from more than 60 indicators will feed into the overall score – and local civil society partners will be supported to use the results in their advocacy work.
As part of the preparation for the global launch, IDPC and WADPN held a series of workshops for our members and other allies involved in drug policy advocacy in Ghana, Senegal, Mozambique, and Kenya to learn more about the Index.
The workshop was in 3 sections, where the first two sections were in-person workshops and an online section for civil society partners and other allies in Ghana and Senegal, Mozambique and Kenya respectively. The workshop explained the GDPI project and methodology, prepared participants for the launch, and provide space for discussion and questions.
Kindly watch the full workshop here: https://youtu.be/HMLlwq76wjw
The GDPI is a collaborative project of the “Harm Reduction Consortium” – led by the International Drug Policy Consortium (IDPC) and the Global Drug Policy Observatory at Swansea University (GDPO), and including the Eurasian Harm Reduction Association (EHRA), the Eurasian Network of People who Use Drugs (ENPUD), the European Network of People who Use Drugs (EuroNPUD), Harm Reduction International (HRI), the Middle East and North Africa Harm Reduction Association (MENAHRA), the West Africa Drug Policy Network (WADPN), the Women and Harm Reduction International Network (WHRIN), and Youth RISE.
This project is funded by the Robert Carr Fund for civil society networks.